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ABSTRACT 
 
Tuberculosis (TB), in which caused by pathogenic bacteria, Mycobacterium tuberculosis, has become the 
major causes of death among all of infectious diseases. The increasing incidence of multidrug-resistant 
tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) has created a need to discover a 
new antituberculosis drug candidate. The aim of this study was to screen extract and fractions of Tinospora 
crispa for activity against Mycobacterium tuberculosis H37Rv using the Microplate Alamar Blue Assay 
(MABA) method. T. crispa extract was prepared by maceration in ethanol (96%) and antituberculosis activity 
was carried out using MABA method. The result of this study showed that ethanolic extract of T. crispa 
exhibit antituberculosis activity with minimum inhibition concentration of 12.5 mg/ml. 
 
ABSTRAK 
 
Tuberkulosis (TB) adalah penyakit yang disebabkan oleh infeksi Mycobacterium tuberculosis dan menjadi 
penyakit infeksi yang menyebabkan paling banyak kematian di dunia. Daruratnya penyakit TB dan 
meningkatnya kasus multidrug-resistant tuberculosis (MDR-TB) dan XDR-TB ini mendorong dilakukannya 
banyak penelitian dan pengembangan obat antiTB baru. Penelitian ini bertujuan untuk mengetahui 
aktivitas antituberkulosis batang Brotowali. Batang Brotowali kering diekstraksi dengan metode maserasi 
menggunakan pelarut etanol 96%. Uji aktivitas antituberkulosis secara in vitro terhadap M. tuberculosis 
H37Rv dilakukan dengan metode Microplate Alamar Blue Assay (MABA). Hasil penelitian menunjukkan 
bahwa ekstrak etanol batang Brotowali memiliki aktivitas antituberkulosis terhadap M. tuberculosis H37Rv 
dengan konsentrasi hambat minimum (KHM) sebesar 12,5 mg/ml. 
 
INTRODUCTION 
Tuberculosis (TB) is an infectious disease 
and the second leading cause of death from a 
single infectious disease in the world after human 
immunodeficiency virus (HIV) (Prabu et al., 
2015). In 2014, TB had caused 1.5 million of 
deaths (World Health Organization, 2015). It 
remains a major global health problem. This 
disease is caused by Mycobacterium tuberculosis, 
an intracelluler obligate and aerobic bacillus that 
multiplies within macrophage.  
TB treatment is generally consist of 
combination of four first line drugs: isoniazid, 
rifampicin, ethambutol, and pyrazinamide for two  
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months and followed by four additional months of 
isoniazid and rifampicin therapy (Nguta et al., 
2015). Unfortunately, in the last few decades, 
multi-drug resistant (MDR-TB) was arised. MDR-
TB is caused by strain of M. tuberculosis that are 
resistant to isoniazid and rifampicin (Keshavjee 
and Farmer, 2012). In 2014, there were 480.000 
MDR-TB cases and estimated 190.000 people died 
because of this disease (World Health 
Organization, 2015). Approximately 9.6% of the 
total MDR-TB cases are classified as extensively 
drug-resisten tuberculosis (XDR-TB) (Nguta et al., 
2015). In this cases, M. tuberculosis strain is not 
only resistant to isoniazid and rifampicin, but also 
resistant to any fluoroquinolones and to at least 
first line injectable antituberculosis drug, i.e 
amikacin, capreomycin, and kanamycin. The 
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emergence of MDR-TB and followed by  XDR-TB 
remains a major challenge to global health. This 
condition led to an urgent need to discover a new 
antituberculosis drug. Many researches are 
focused on the discovery and development of new 
antituberculosis drugs from natural product 
(Chinsembu, 2016). It can be done by screen novel 
compound from a natural product such as plant 
species (Alvin et al., 2014).  Natural products are 
considered as potential anti-TB agents (Nguta et 
al., 2015) 
Tinospora crispa (L.) Miers ex 
Hook.f.Thoms) is a member of Menispermaceae. It 
is widely known as Brotowali in Indonesia. It is 
widely distributed over tropical and subtropical 
Asia including India, Thailand, Vietnam, 
Philippines, Indonesia, and Malaysia (Chang et al., 
2015). This plant is commonly used as traditional 
medicine, especially its stem. The stem of T. crispa 
is traditionally used to treat tuberculosis. Some 
preliminary research reported the activity of T. 
crispa against M. tuberculosis. Ethanolic extract of 
T. crispa from Laos has antimycobacterial activity 
against M. tuberculosis with minimum inhibitory 
concentration (MIC) 2,43 – 96,2 µg/ml (Elkington 
et al., 2014). But there has been no report about 
the antimycobacterial activity of T. crispa that 
grows in Indonesia and its fractions or isolates. 
The present study determined the 
antimycobacterial activity of ethanolic extract of 
T. crispa collected from Indonesia using 
microplate alamar blue assay (MABA) method.  
 
METHODOLOGY 
An antituberculosis activity using MABA 
assay was conducted in Tuberculosis Laboratory 
(BSL 2+), Faculty of Medicine, Universitas Gadjah 
Mada. Extraction and fractionation procedures 
were conducted in Department of Pharmaceutical 
Biology, Faculty of Pharmacy, Universitas Gadjah 
Mada. 
 
Bacterial strain 
M. tuberculosis H37Rv was obtained from 
Tuberculosis Laboratory, Faculty of Medicine, 
Universitas Gadjah Mada. This bacteria was 
subcultured on Lowenstein Jensen (LJ) medium. 
Suspension of log phase M. tuberculosis H37RV 
was prepared in 0.04% (v/v) Tween 80 and 0.2% 
bovine serum albumin (Sigma) so that their 
turbidities matches that of a Mc.Farland no.1 
turbidity standard. The turbidity was examined by 
weighing method (Kemenkes RI, 2012). 
Suspension was further diluted 1:25 in 7H9GC 
broth (4.7g of Middlebrook 7H9 broth base,             
20mL of 10% glycerol, 880mL of distilled water, 
100mL of OADC (oleic acid, albumin, dextrose, 
catalase)). 
Chemicals and media 
Middlebrook 7H9 broth (Difco), glycerol 
(Merck), OADC (oleic acid, albumin, dextrose, 
catalase; Becton Dickinson), Tween 80 (Sigma), 
Alamar Blue reagent (Invitrogen), sterile water, 
dimethyl sulfoxide, isoniazide (Fluka), rifampicin 
(Sigma), ethanol 96%, n-hexane, ethyl acetate, 
silika gel F254 plate (Merck), ceric sulfate.  
 
Plant material 
Stems of T. crispa were collected in 
February 2016 from Sleman, Yogyakarta, 
Indonesia, and were authenticated in Department 
of Pharmaceutical Biology, Faculty of Pharmacy, 
Universitas Gadjah Mada.  
 
Extraction 
Dried and ground plant material (500 g) 
was extracted at room temperature by maceration 
method with ethanol 96% and repeated twice. 
Extraction process was done twice to get more 
effective extraction so that more compounds can 
be extracted. The extracts were then condensed 
using a Buchi rotary evaporator (rotavapor).  
 
Fractionation 
The extract was fractionated using 
trituration method. The ethanolic extract (5 g) 
was added with n-hexane and then shaken for 10 
minutes. After shaking, it was filtered with 
sinterglass, then the filtrate were collected. The 
fractionation with n-hexane was conducted three 
times. The collected filtrate was condensed using 
a Buchi rotary evaporator (rotavapor) and it was 
called n-hexane fraction (F1). The residue, called 
n-hexane non-soluble fraction (F2), was then 
added with ethyl acetate and then shaken for 10 
minutes. After shaking, it was filtered with 
sinterglass and the filtrate were collected. The 
fractionation with ethyl acetate was conducted 
three times. The collected filtrate condensed using 
a Buchi rotary evaporator (rotavapor) and called 
ethyl acetate fraction (F3). The residue was called 
ethyl acetate non-soluble fraction (F4).  
 
Microplate Alamar Blue Assay (MABA) 
antituberculosis test 
Antimycobacterial assay was perform        
using the Microplate Alamar blue assay (MABA) 
(Franzblau et al., 1998). This assay was performed 
in 96-well microplates (Iwaki). Outer perimeter 
wells were filled with 200µL of sterile               
water to minimize evaporation of the medium                
in   the   experimental    wells    during   incubation.  
One hundred microliters of 7H9GC broth were 
added to experimental wells. One hundred 
microliters of 100 mg/ml sample solution (extract 
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or fraction) were added to the wells in row B and 
C in columns 2, 3, and 4. By using micropippete, 
100µL was trasferred from row C to D and the 
contents of the wells were mixed well. This 
dilutions were continued through row G, and 
100µL of excess medium was discarded from the 
wells in row G. Final extract concentration were 
100; 50; 25; 12.5; 6.25 and 3.125 mg/ml (from 
row B to G). In the previous assay (not reported in 
this paper), we used final concentration ranges of 
62.5 to 2000 µg/ml, but the result showed that it 
were not active. So, in the last assay, we used 
greater concentration of samples up to 
100mg/mL. Row B to D columns 8 were used to 
isoniazide 10µg/mL as positive controls. Row B to 
D columns 9 were used to rifampicin 10µg/mL as 
positive controls. Row B to D columns 10 were 
used to dimethyl sulfoxide 4% as solvent controls. 
The wells in columns 11 served as sample-free 
(inoculum only) controls. One hundred 
microliters of M. tuberculosis suspension was 
added to the wells in row B to G in columns 2 to 
11 yielding a final volume of 200µL per well. The 
plates were sealed with parafilm and were 
incubated at 37°C for 5 days. Starting at day 6 of 
incubation, 50µL of freshly prepared 1:1 mixture 
of Alamar Blue reagent and 10% Tween 80 was 
added to well B11 and plate were reincubated at 
37°C for 24 h. If B11 became pink by 24 h, the 
reagent mixture was added to the entire plate (if 
the well remained blue, the reagent mixture 
would be added to another control well and the 
result would be read on the following day). The 
microplates were resealed with parafilm and were 
incubated for an additional 24 h at 37˚C, and the 
colors of all well were recorded. A blue color in 
the well was interpreted as no growth and a pink 
color was scored as growth. The Minimum 
Inhibitory Concentration (MIC) was defined as the 
lowest concentration of samples which prevented 
a color change from blue to pink.  
 
RESULTS AND DISCUSSION 
T. crispa is a well-known source of herbal             
plant which is used traditionally as medications 
for diabetes mellitus, hypercholesterolemia and 
also hepatoprotective (Abu et al., 2015). In order 
to screen the potentiality of T. crispa as 
antituberculosis candidate, ethanolic extract of 
the stem of T. crispa was tested againts M. 
tuberculosis using Microplate Alamar Blue Assay 
(MABA). 
MABA is a microplate method that used as 
high-throughput screen antituberculosis activity 
of samples. This method used Alamar blue, a 
resazurin-based oxidation-reduction based 
indicator.  This  indicator  delivered  colorimetric 
MIC for M. tuberculosis in 14 days (Franzblau et 
al., 1998). In this research, MIC for Ethanolic 
extract of Brotowali was available after 7 days of 
incubation.  MABA  is  more  effective  and 
efficient  than  other  method  to  determine  drug 
or samples susceptibilities. M. tuberculosis is a 
slow  growing  mycobacteria  and  this  method 
has significantly decrease the time to get the 
result. Biosafety cabinet, autoclave, and 37˚C 
incubator are minimum major equipment to 
perform MABA. 
Alamar blue dye is general indicator of 
celular growth and or viability; the blue and 
nonfluorescent. It is in blue color in the oxidized 
state, but it turns pink when reduced due to 
bacterial metabolism. Therefore, the growth of M. 
tuberculosis can be measured with fluorometer or 
spectrophotometer or determined by a visual 
color change (Collins and Franzblau, 1997).  This 
is the major advantage of MABA. In this research, 
the growth of M. tuberculosis was determined by 
visual color change, without the use of specialized 
equipment. Collins and Franzblau (1997) reported 
that there were no statistically significant 
differences among MICs determined by 
fluorometric and visual MABA. The two colors 
(blue and pink) can be easily differentiated with 
the naked eye. Visual readout is the most 
frequently used in evaluation of antituberculosis 
compounds (Franzblau et al., 2012). 
MABA has a low possibility to resulting 
aerosols of M. tuberculosis suspension from well, 
so it can reduce the possibility of researcher may 
be infected during the assay. It is the other 
advantage of MABA method from biosafety 
perspective. H37Rv is a virulent strain of M. 
tuberculosis. This strain is still sensitive to 
rifampicin and isoniazide as antituberculosis drug 
used in tuberculosis therapy. H37Rv is the most 
strain used by laboratories in antituberculosis 
screening (Franzblau et al., 2012).  
Different culture media are in use for the 
isolation of mycobacteria. The most common is 
Lowenstein-Jensen (LJ) medium. It is an egg based 
medium with high concentrations of malachite 
green to overcome contamination with other 
bacteria. However, culture on it is long (3 weeks 
to 3 months for M. tuberculosis) and time 
consuming. In this research, we used Middlebrook 
7H9 broth-based as the most media used in 
microplate-based assay. Glycerol was added as 
carbon source for culturing M. tuberculosis. While 
Tween 80 was used to minimize clumping of 
mycobacteria during growth. 
Traditional Medicine Journal, 22(2), 2017  127 
Table I. Antimycobacterial activity results of T. crispa ethanolic extract and its fraction using MABA 
method 
 
No Sample name Code Concentration (mg/ml) Result 
1 Ethanolic extract of T. crispa stem EEB 
100 Active 
50 Active 
25 Active 
12.5 Active 
6.25 Not active 
3.125 Not active 
2 n-hexane soluble fraction  F1 
2 Not active 
1 Not active 
0.5 Not active 
0.25 Not active 
0.125 Not active 
0.0625 Not active 
3 n-hexane non soluble fraction F2 
2 Not active 
1 Not active 
0.5 Not active 
0.25 Not active 
0.125 Not active 
0.0625 Not active 
4 Ethyl acetate soluble fraction F3 
2 Not active 
1 Not active 
0.5 Not active 
0.25 Not active 
0.125 Not active 
0.0625 Not active 
5 Ethyl acetate non soluble fraction F4 
2 Not active 
1 Not active 
0.5 Not active 
0.25 Not active 
0.125 Not active 
0.0625 Not active 
6 Isoniazid 10 µg/ml K+ 0.01 Active 
7 Rifampisin 10 µg/ml K+ 0.01 Active 
8 DMSO 4% Kp  Not active 
 
 
Sample was categorized as active if it can 
prevent a color change from blue to pink. In this 
study, we tested extract and fraction of T. crispa 
with 100 mg/ml as the highest concentration 
because it were not active under 100 µg/ml. Most 
paper suggested that plants extract considered 
had significant antituberculosis activity if MIC was 
< 100µg/mL. There were many different reference 
to analyze the antituberculosis activity of plant 
extracts. In previous study, plants extract were 
considered active against M. tuberculosis if         
MIC was <100µg/mL (Borges-Argáez et al., 2007; 
Gautam et al., 2007; Okunade et al., 2004), 
<200µg/mL (Camacho-Corona et al., 2008; Tosun 
et al., 2004), < 1600µg/mL (Mohamad et al., 
2011), ≤ 2048 µg/ml (Tekwu et al., 2012). In other 
paper, the antimicrobial activity of plant extracts 
was classified as significant (MIC ≤100µg/mL), 
moderate (100 < MIC < 625µg/mL), or weak (MIC 
> 625 µg/mL) (Kuete, 2010). Because of ethanolic 
extract of Brotowali exhibited antituberculosis 
activity against M. tuberculosis H37Rv with MIC 
12.5mg/mL, so we interpreted that this activity 
was weak. 
The results of antituberculosis assay of 
extract and its fractions against M. tuberculosis 
H37Rv are shown in Table 1. These results 
showed that from T. crispa extract and fractions 
tested, ethanolic extract of Brotowali exhibited 
antituberculosis activity against M. tuberculosis 
H37Rv with MIC 12.5mg/mL. This was 
contradictive  with  the result of previous research 
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Figure 1. Thin layer chromatography profile of Brotowali ethanolic extract and its fraction on silica gel 60 
F254 plate as stationary phase, and chloroform:methanol (9:1) as mobile phase. A : under uv 254 nm 
detection; B : under uv 366 nm detection; C : after sprayed by ceric sulfate. 
 
that ethanolic extract of T. crispa from Laos has 
antimycobacterial activity against M. tuberculosis 
with minimum inhibitory concentration (MIC) 
2,43-96,2µg/mL. The difference of plant materials 
collection location could be one of the reason of 
this different results. Different type of soil, 
different organic component in soil can influence 
the secondary metabolite contains in plant. This 
can affect the biological and pharmacology 
activity of the plant. 
The fractions (F1, F2, F3, and F4) were 
result of separation procedures of T. crispa 
extract. This separation procedures were 
conducted to separate the compound content in 
the extract based on its polarity properties. n-
hexane fraction (F1) contains non polar 
compounds, n-hexane non-soluble fraction 
contains compounds that its more polar than F1. 
Ethyl acetate fraction (F3) contains semi-polar 
compounds and ethyl acetate non-soluble fraction 
(F4) contains polar compounds. So, if the result of 
antituberculosis assay of fractions were active and 
potential to be developed as new antituberculosis 
drug candidates, it will become easier to isolate 
the active compound from the active fraction. 
Unfortunately, all fractions did not exhibited 
antituberculosis activity against M.tuberculosis 
H37Rv. 
Based on chromatogram on figure 1, 
Brotowali ethanolic extract axhibited a clear 
seperation using chloroform and methanol as 
mobile phase. n-hexane soluble fraction (F1) 
contains non-polar compounds dominantly, while 
the polar compounds contained in the ethyl 
acetate non soluble fraction (F4). T. crispa 
contains a wide range of secondary metabolites 
such as alkaloids, terpens, flavons and phenolics 
(Koay and Koay, 2013). This compounds exhibited 
antitubercular activity (Okunade, et al., 2004; 
Garcia et al., 2012). But, in this research, we did 
not do any test to find out which compounds in T. 
crispa extract had the responsibility of the 
antituberculosis activity. 
 
CONCLUSIONS 
In conclusion, our data show that ethanolic 
extract of T. crispa has weak antituberculosis 
activity against M. tuberculosis with MIC of 12.5 
mg/ml. 
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